Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results

The objective of this study was to assess the frequency of comorbidities and multimorbidities in rheumatoid arthritis (RA) patients under biologic therapy and their effects on biological disease modifying antirheumatic drugs (DMARDs) choice, timing, and response. Hacettepe University Biologic Regist...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: Armagan, Berkan, Sari, Alper, Erden, Abdulsamet, Kilic, Levent, Erdat, Efe Cem, Kilickap, Saadettin, Kiraz, Sedat, Bilgen, Sule Apras, Karadag, Omer, Akdogan, Ali, Ertenli, Ihsan, Kalyoncu, Umut
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2018
Témata:
6900
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5895384/
https://ncbi.nlm.nih.gov/pubmed/29595700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000009930
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky